Navigation Links
Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
Date:1/6/2009

nder "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the SEC on March 17, 2008, and other factors detailed from time to time in the Company's other filings with the SEC, available at www.sec.gov. The Company undertakes no obligation to update or advise upon any such forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals develops pharmaceutical products for treatment of addiction and other neurological disorders. The company supports third-party academic, educational and therapeutic advances in both these areas of research. Rock Creek has scientific and research offices in Gloucester, MA.

About Star Scientific

Star Scientific is a technology-oriented tobacco company with a toxin reduction mission. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins (principally tobacco specific nitrosamines, or TSNAs), through the utilization of the innovative StarCured(R) tobacco curing technology, and in sublicensing that technology to others. Star Scientific has a Corporate and Sales Office in Petersburg, VA, an Executive, Scientific & Regulatory Affairs office in Bethesda, MD, and manufacturing facilities in Chase City, VA.

See Star's website at: http://www.starscientific.com


'/>"/>
SOURCE Star Scientific
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Sky One Medical, Inc. Receives Scientific Achievement Award
2. NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research
3. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
4. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
5. Decision Biomarkers Inc Announces Formation of Scientific Advisory Board
6. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
7. Milestone Scientific to Showcase STA(TM) System at the Greater New York Dental Meeting in New York City
8. Boston Scientific to Participate in Piper Jaffray Health Care Conference
9. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
10. Recognized Dermatology Expert Dr. Zoe Draelos Joins Histogen Scientific Advisory Board
11. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... inventions licensed to biotechnology firms has revealed early ... these roadblocks, the researchers suggest that better communication ... could lead to faster commercialization down the road. ... made in university laboratories and licensed to biotechnology ... which have a high failure rate. But a ...
(Date:8/20/2014)... succeeded in measuring vibrational motion of a single molecule ... vibration of a single molecule differs from the behaviour ... performed at the University of California, Irvine, where post-doctoral ... as a visiting fellow under professor Vartkess A. Apkarian, ... was lead by Professor Eric O. Potma. The results ...
(Date:8/20/2014)... High performance computing (HPC) will be ... climate and Earth system model to address the ... Eight national laboratories, including Lawrence Livermore , ... Atmospheric Research, four academic institutions and one private-sector ... laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los Alamos, ...
(Date:8/20/2014)... 2014  PAREXEL International Corporation (NASDAQ: PRXL ... the Baird Healthcare Conference in New York.  Ingo ... will be making a presentation on PAREXEL and discussing ... 3, 2014. A live webcast of the ... PAREXEL,s website at www.PAREXEL.com in the Upcoming ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Seeing a molecule breathe 2New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3PAREXEL International To Present At Baird Healthcare Conference 2
... Inc., a,privately-held, development-stage pharmaceutical company dedicated to treating,diseases ... defenses, today,announced that the National Institutes of Health ... excess of $850,000. , ... to advance the development of safe and,effective medical ...
... InSightec Ltd.,announced today that cancer patients suffering pain ... have a new online resource for information about,their ... bone metastases, as well as detailed information about ... the U.S., Canada and,Israel to evaluate whether treatment ...
... Who Can Benefit from Vectibix(R) , ... Amgen (Nasdaq: AMGN ) today announced they ... gene as a predictive biomarker in patients with ... receptor (EGFr) antibody Vectibix(R) (panitumumab) with the U.S. Food ...
Cached Biology Technology:Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury 2Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury 3MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases 2MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases 3Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 2Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 3Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 4Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 5Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 6Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 7Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting 8
(Date:8/20/2014)... -- Bay Area Lyme Foundation, which aims to make ... applauds new research published in an upcoming issue of ... Diseases . The findings show that ticks that ... the year, making the threat of Lyme disease year-round. ... of Public Health (CDPH) Vector-borne Disease Section and University ...
(Date:8/20/2014)... that acral melanomas the rare type of skin cancer ... distinct from other more common types of skin cancer, according ... Pigment Cell & Melanoma Research . , Acral melanoma ... the feet, nail-beds and other hairless parts of the skin. ... by UV damage from the sun. , The team, from ...
(Date:8/20/2014)... and salty aroma of sunscreen and seawater signals a ... reporting that the idyllic beach vacation comes with an ... and into the sea, they can become toxic to ... main course for many other marine animals. Their study ... Technology . , Antonio Tovar-Sanchez and David Snchez-Quiles point ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Scientists learn more about rare skin cancer that killed Bob Marley 2
... improve its system for ensuring the safety of its ... Academy of Sciences say. Despite having 40% of the ... independent regulatory agency and sufficient staff to keep pace ... article in ACS,s journal Environmental Science & Technology. ...
... The obscure technology used in heated automobile seats, gadgets that ... devices is undergoing a renaissance and could well emerge as ... play other key roles in addressing some of society,s most ... the technology termed thermoelectrics in the current issue ...
... Elser, Argentina,s soaring, glacier-laden peaks, ancient cultures, and criollo ... draw: access to the "last unpolluted aquatic ecosystems on ... Elser and colleague Esteban Balseiro of the Universidad Nacional ... alpine lakes close to San Carlos de Barliloche in ...
Cached Biology News:Fulbright scholar takes ecological theory to Andean heights 2Fulbright scholar takes ecological theory to Andean heights 3
... exciting new chapter to a ... Agilents 7890A GC gives you ... your lab to the next ... performance, including advanced separation capabilities, ...
... often call for critical, but time-consuming ... refines siRNA transfection protocols resulting in ... can be used to efficiently transfect ... without increased cytotoxicity. From start ...
... CaspaTag™ Pan-Caspase In Situ Assay Kit is ... caspases in cells undergoing apoptosis. The kit ... use in diagnostic or therapeutic procedures. CHEMICON®s ... a novel approach to detect active caspases. ...
... INTERFERin is a new-generation siRNA transfection ... efficiency at 1 nM siRNA in a ... with excellent cell viability. Using low siRNA ... effects observed when transfecting siRNA at higher ...
Biology Products: